Delhi, 16 May (H.S): The Indian government has recently taken a significant step towards making healthcare more accessible and affordable for its citizens. In a bid to reduce the financial burden on individuals suffering from common ailments, the government has reduced the prices of 41 commonly used medicines and six formulations used to treat diseases such as diabetes, heart and liver ailments.

This includes antacids, multivitamins, and antibiotics – all of which are essential in treating various health conditions. The Department of Pharmaceuticals and National Pharmaceutical Pricing Authority (NPPA) have instructed pharmaceutical companies to pass on the information on the reduced prices to dealers and stockists immediately.

This decision was taken at the 143rd meeting of the NPPA, with the aim of ensuring that the cost of essential medicines remains affordable for the public. With over 10 crore diabetes patients in India, one of the highest numbers in the world, this price reduction is expected to benefit a significant portion of the population. This move follows the release of annual revised ceiling prices for 923 scheduled drug formulations and revised retail prices for 65 formulations by the Department of Pharmaceuticals last month. This step by the government is a welcome move towards making healthcare more accessible for all individuals in the country.

Hindusthan Samachar/ Indrani Sarkar